title: [Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: Date: 02/07/2014].
authors.affiliation: Augenabteilung, St. Franziskus-Hospital Münster, Hohenzollernring 74, 48145, Münster, Deutschland, arnd.heiligenhaus@uveitis-zentrum.de.
authors.forename: A
authors.initials: A
authors.lastname: Heiligenhaus
authors.forename: B
authors.initials: B
authors.lastname: Bertram
authors.forename: C
authors.initials: C
authors.lastname: Heinz
authors.forename: L
authors.initials: L
authors.lastname: Krause
authors.forename: U
authors.initials: U
authors.lastname: Pleyer
authors.forename: J
authors.initials: J
authors.lastname: Roider
authors.forename: S
authors.initials: S
authors.lastname: Sauer
authors.forename: S
authors.initials: S
authors.lastname: Thurau
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D005858:Germany; D006801:Humans; D058449:Intravitreal Injections / Q000592:standards*; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology; D009885:Ophthalmology / Q000592:standards; D014605:Uveitis / Q000150:complications* / Q000188:drug therapy*
chemical_list: D000305:Adrenal Cortex Hormones; D020533:Angiogenesis Inhibitors; D000893:Anti-Inflammatory Agents